FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to biologically active peptides capable to reduce death rate caused by acute blood loss. The application of octapeptide H-Phe-Nle-Phe-Gln-Gly-Gln-Arg-Phe-NH2 (I) amide and its pharmaceutically acceptable salts as an agent for increasing survival rate after acute blood loss.
EFFECT: peptide described above effectively increases survival rate after acute blood loss.
1 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
OCTAPEPTIDE AMIDE, CAPABLE OF RAISING BLOOD PRESSURE AND CARDIAC RATE | 2007 |
|
RU2346001C1 |
METHOD OF SEVERE HEMORRHAGE SHOCK TREATMENT | 1992 |
|
RU2092181C1 |
THERAPY MONITORING IN TREATMENT WITH BINDING AGENT AGAINST ADRENOMEDULLIN (ADM) | 2018 |
|
RU2776811C2 |
PEPTIDE GLP-2 AGONISTS | 2010 |
|
RU2551977C2 |
PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
LONG-ACTING CO-AGONISTS OF GLUCAGON AND GLP-1 RECEPTORS | 2018 |
|
RU2779314C2 |
PARATHYROID HORMONE ANALOGUES FOR OSTEOPOROSIS TREATMENT | 1997 |
|
RU2203286C2 |
SLIGHTLY SOLUBLE RELEASING HORMONE-LUTEONIZING HORMONE ANALOG SALT, SLIGHTLY SOLUBLE BOMBESINE ANALOG SALT, PHARMACEUTICAL COMPOSITION, MEDICINAL PREPARATION | 1994 |
|
RU2152222C1 |
HIGH-PENETRATION PRODRUG COMPOSITIONS BASED ON PEPTIDES AND PEPTIDE-RELATED COMPOUNDS | 2010 |
|
RU2767051C2 |
A-I APOLIPOPROTEIN MIMETICS | 2010 |
|
RU2532222C2 |
Authors
Dates
2010-11-20—Published
2009-04-29—Filed